Diagnoptics News
What's new?
Read all news items about the AGE Reader and Diagnoptics.
AGE Reader approved as medical device in Mexico
The AGE Reader has received its market approval from COFEPRIS in Mexico. “We have been working on this for a long time with our partner PDE in Mexico, says Bart van den Berg, CEO of Diagnoptics. Perseverance was needed because the severe hit by Covid caused a significant delay.” PDE, or Prevención Y Detección Especializada, is specialized in early detection of disease like breast cancer, cardiovascular disease and diabetes. The availability of the AGE Reader in Mexico will certainly improve the prevention from these devastating diseases. The introduction of the AGE Reader and education of the medical society has already started, so people in Mexico may expect the opportunity to be checked on their health risks soon.
The AGE Reader provides an immediate cardiovascular risk prediction in 12 Seconds. It has been designed for patient friendly diagnosis and allows doctors to practice personalized care and prevent disease (progression). As an optical measurement of the skin is used, it is noninvasive and provides an alternative to cost-intensive laboratory tests. The method is convenient, easy to use and extensively validated.
If you would like to receive further information regarding the AGE Reader, please do not hesitate to contact us. If you are based in Mexico, please contact PDE directly on contact PDE.
Latest news items
Would you like to learn more about our products? Request any information you wish to receive here.
If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.
More information about Diagnoptics.
Information on Diagnoptics' products and Advanced Glycation Endproducts.
Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.